Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Disparity implications of Medicare eligibility criteria for medication therapy management services.

Wang J, Mullins CD, Brown LM, Shih YC, Dagogo-Jack S, Hong SH, Cushman WC.

Health Serv Res. 2010 Aug;45(4):1061-82. doi: 10.1111/j.1475-6773.2010.01118.x. Epub 2010 May 24.

2.

Race, treatment preferences, and hospice enrollment: eligibility criteria may exclude patients with the greatest needs for care.

Fishman J, O'Dwyer P, Lu HL, Henderson HR, Asch DA, Casarett DJ.

Cancer. 2009 Feb 1;115(3):689-97. doi: 10.1002/cncr.24046. Erratum in: Cancer. 2014 Jan 1;120(1):154. Henderson, Hope [corrected to Henderson, Hope R].

3.

Medication therapy management and cost-related medication nonadherence.

Guirguis AB, Zingone MM.

JAMA. 2008 Sep 10;300(10):1130; author reply 1130-1. doi: 10.1001/jama.300.10.1130-a. No abstract available.

PMID:
18780839
4.

Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007.

Schommer JC, Planas LG, Johnson KA, Doucette WR.

J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):478-86. doi: 10.1331/JAPhA.2008.08023.

PMID:
18647710
5.

When does a difference become a disparity? Conceptualizing racial and ethnic disparities in health.

Hebert PL, Sisk JE, Howell EA.

Health Aff (Millwood). 2008 Mar-Apr;27(2):374-82. doi: 10.1377/hlthaff.27.2.374.

6.

Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.

Wang J, Zuckerman IH, Miller NA, Shaya FT, Noel JM, Mullins CD.

Health Serv Res. 2007 Aug;42(4):1499-519.

7.

Disparities in health care: minority elders at risk.

Byrd L, Fletcher A, Menifield C.

ABNF J. 2007 Spring;18(2):51-5.

PMID:
17608287
8.

The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors.

Wang J, White-Means SI, Hufstader MA, Walker GD.

Curr Med Res Opin. 2007 Apr;23(4):853-63.

PMID:
17407642
10.

Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.

Wang J, Noel JM, Zuckerman IH, Miller NA, Shaya FT, Mullins CD.

Med Care Res Rev. 2006 Dec;63(6):742-63.

PMID:
17099124
11.

Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries.

Gaskin DJ, Briesacher BA, Limcangco R, Brigantti BL.

Am J Geriatr Pharmacother. 2006 Jun;4(2):96-111.

PMID:
16860257
12.

Definition of medication therapy management: development of professionwide consensus.

Bluml BM.

J Am Pharm Assoc (2003). 2005 Sep-Oct;45(5):566-72.

PMID:
16295641
13.

Racial disparities in prescription drug use for mental illness among population in US.

Han E, Liu GG.

J Ment Health Policy Econ. 2005 Sep;8(3):131-43.

PMID:
16278501
14.

Medicare as a catalyst for reducing health disparities.

Eichner J, Vladeck BC.

Health Aff (Millwood). 2005 Mar-Apr;24(2):365-75.

15.

Medicare program; Medicare prescription drug benefit. Final rule.

Centers for Medicare & Medicaid Services (CMS), HHS..

Fed Regist. 2005 Jan 28;70(18):4193-585.

16.

Racial disparities in prescription drug use among dually eligible beneficiaries.

Schore J, Brown R, Lavin B.

Health Care Financ Rev. 2003 Winter;25(2):77-90.

17.

Racial and ethnic disparities in prescription coverage and medication use.

Briesacher B, Limcangco R, Gaskin D.

Health Care Financ Rev. 2003 Winter;25(2):63-76.

18.
19.
20.

Supplemental Content

Support Center